|
|
|
Acne Clinical Trials, Diagnosis, and Treatment |
|
Thank you for your interest in clinical trials for Acne.
Please click "Search" to find Acne clinical trials and medical research studies
or read below for information on Acne diagnosis and treatment.
If you receive too many study listings you may enter your zip code to find the
locations closest to you.
|
|
|
|
|
Results from Clinical Connection:
|
|
|
|
Your search returned 22 studies:
|
|
|
|
|
Results from other databases:
|
|
|
|
Your search returned 111 studies:
- "A Randomized, Controlled, Evaluator-blinded Pilot Study to Evaluate the Effect of Automated Text Message Reminders on Patient Compliance With Topical Medications and Its Efficacy on Skin Disease Control in Adolescents and Adults With Mild to Moderate Acn
Conditions: Acne - Patient Compliance Location: Dallas, TX
- A Study to Evaluate the Efficacy of Silk - Like Bedding Fabric, as Used in a Standard Pillow Case, in the Treatment of Acne Vulgaris - NCT00767104-27157
Conditions: Acne Vulgaris Location: Winston-Salem, NC
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017120-02919
Conditions: Acne Vulgaris Location: Johnston, RI
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017120-14623
Conditions: Acne Vulgaris Location: Rochester, NY
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017120-23507
Conditions: Acne Vulgaris Location: Norfolk, VA
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017120-30022
Conditions: Acne Vulgaris Location: Alpharetta, GA
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017120-30078
Conditions: Acne Vulgaris Location: Snellville, GA
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017120-33175
Conditions: Acne Vulgaris Location: Miami, FL
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017120-40202
Conditions: Acne Vulgaris Location: Louisville, KY
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017120-47714
Conditions: Acne Vulgaris Location: Evansville, IN
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017120-48084
Conditions: Acne Vulgaris Location: Troy, MI
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017120-48202
Conditions: Acne Vulgaris Location: Detroit, MI
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017120-68144
Conditions: Acne Vulgaris Location: Omaha, NE
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017120-77056
Conditions: Acne Vulgaris Location: Houston, TX
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017120-78229
Conditions: Acne Vulgaris Location: San Antonio, TX
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017120-90404
Conditions: Acne Vulgaris Location: Santa Monica, CA
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017146-11790
Conditions: Acne Vulgaris Location: Stony Brook, NY
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017146-19067
Conditions: Acne Vulgaris Location: Yardley, PA
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017146-27157
Conditions: Acne Vulgaris Location: Winston Salem, NC
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017146-27262
Conditions: Acne Vulgaris Location: High Point, NC
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017146-33140
Conditions: Acne Vulgaris Location: Miami Beach, FL
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017146-37203
Conditions: Acne Vulgaris Location: Nashville, TN
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017146-37922
Conditions: Acne Vulgaris Location: Knoxville, TN
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017146-44118
Conditions: Acne Vulgaris Location: South Euclid, OH
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017146-45220A
Conditions: Acne Vulgaris Location: Cincinnati, OH
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017146-45220B
Conditions: Acne Vulgaris Location: Cincinnatti, OH
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017146-46260
Conditions: Acne Vulgaris Location: Indianapolis, IN
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017146-53209
Conditions: Acne Vulgaris Location: Milwaukee, WI
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017146-55432
Conditions: Acne Vulgaris Location: Fridley, MN
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017146-75230
Conditions: Acne Vulgaris Location: Dallas, TX
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017146-77845
Conditions: Acne Vulgaris Location: College Station, TX
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017146-78759
Conditions: Acne Vulgaris Location: Austin, TX
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017146-80209
Conditions: Acne Vulgaris Location: Denver, CO
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017146-87106
Conditions: Acne Vulgaris Location: Albuquerque, NM
- A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - NCT01017146-97210
Conditions: Acne Vulgaris Location: Portland, OR
- A Study to Examine the Safety and Efficacy Of Drospirenone and Ethinyl Estradiol (YAZ) Compared With Placebo In The Treatment Of Moderate Truncal Acne Vulgaris - NCT00722761-02114
Conditions: Acne Vulgaris Location: Boston, MA
- Apremilast in the Treatment of Moderate to Severe Acne - NCT01074502-27516
Conditions: Acne Location: Chapel Hill, NC
- Comparison of the RevLite Electro-optic Q-Switched Neodymium-doped Yttrium Aluminium Garnet (EO QS Nd:YAG) Laser to a Fractionated Laser System - NCT00955461-10075
Conditions: Photodamage - Irregular Pigmentation - Acne Scars Location: New York, NY
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-01830
Conditions: Severe Nodular Acne Location: Haverhill, MA
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-08009
Conditions: Severe Nodular Acne Location: Berlin, NJ
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-19103
Conditions: Severe Nodular Acne Location: Philadelphia, PA
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-29651
Conditions: Severe Nodular Acne Location: Greer, SC
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-30263
Conditions: Severe Nodular Acne Location: Newnan, GA
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-30327
Conditions: Severe Nodular Acne Location: Atlanta, GA
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-32073
Conditions: Severe Nodular Acne Location: Orange Park, FL
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-32174
Conditions: Severe Nodular Acne Location: Ormond Beach, FL
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-32204
Conditions: Severe Nodular Acne Location: Jacksonville, FL
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-32216
Conditions: Severe Nodular Acne Location: Jacksonville, FL
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-34741
Conditions: Severe Nodular Acne Location: Kissimmee, FL
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-35205
Conditions: Severe Nodular Acne Location: Birmingham, AL
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-37215
Conditions: Severe Nodular Acne Location: Nashville, TN
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-37934
Conditions: Severe Nodular Acne Location: Knoxville, TN
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-42303
Conditions: Severe Nodular Acne Location: Owensboro, KY
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-44118
Conditions: Severe Nodular Acne Location: South Euclid, OH
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-46168
Conditions: Severe Nodular Acne Location: Plainfield, IN
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-46256
Conditions: Severe Nodular Acne Location: Indianapolis, IN
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-46617
Conditions: Severe Nodular Acne Location: South Bend, IN
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-48059
Conditions: Severe Nodular Acne Location: Fort Gratiot, MI
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-48706
Conditions: Severe Nodular Acne Location: Bay City, MI
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-55432
Conditions: Severe Nodular Acne Location: Fridley, MN
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-68144
Conditions: Severe Nodular Acne Location: Omaha, NE
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-71913
Conditions: Severe Nodular Acne Location: Hot Springs, AR
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-76011
Conditions: Severe Nodular Acne Location: Arlington, TX
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-77056
Conditions: Severe Nodular Acne Location: Houston, TX
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-78229A
Conditions: Severe Nodular Acne Location: San Antonio, TX
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-78229B
Conditions: Severe Nodular Acne Location: San Antonio, TX
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-80220
Conditions: Severe Nodular Acne Location: Denver, CO
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-83687
Conditions: Severe Nodular Acne Location: Nampa, ID
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-83704
Conditions: Severe Nodular Acne Location: Boise, ID
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-84124
Conditions: Severe Nodular Acne Location: Salt Lake City, UT
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-90045
Conditions: Severe Nodular Acne Location: Los Angeles, CA
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-92056
Conditions: Severe Nodular Acne Location: Oceanside, CA
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-92117
Conditions: Severe Nodular Acne Location: San Diego, CA
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-94538
Conditions: Severe Nodular Acne Location: Fremont, CA
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-97210
Conditions: Severe Nodular Acne Location: Portland, OR
- Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne - NCT00975143-99204
Conditions: Severe Nodular Acne Location: Spokane, WA
- Efficacy and Safety Study With Visonac Photodynamic Therapy (PDT) - NCT00933543-92123
Conditions: Acne Vulgaris Location: San Diego, CA
- Epiduo Pediatric Acne Study - NCT01138735-17033
Conditions: Acne Location: Hershey, PA
- Epiduo Pediatric Acne Study - NCT01138735-27157
Conditions: Acne Location: Winston-Salem, NC
- Epiduo Pediatric Acne Study - NCT01138735-27262
Conditions: Acne Location: High Point, NC
- Epiduo Pediatric Acne Study - NCT01138735-29607
Conditions: Acne Location: Greenville, SC
- Epiduo Pediatric Acne Study - NCT01138735-33027
Conditions: Acne Location: Miramar, FL
- Epiduo Pediatric Acne Study - NCT01138735-35233
Conditions: Acne Location: Birmingham, AL
- Epiduo Pediatric Acne Study - NCT01138735-37660
Conditions: Acne Location: Kingsport, TN
- Epiduo Pediatric Acne Study - NCT01138735-40202
Conditions: Acne Location: Louisville, KY
- Epiduo Pediatric Acne Study - NCT01138735-44118
Conditions: Acne Location: South Euclid, OH
- Epiduo Pediatric Acne Study - NCT01138735-45229
Conditions: Acne Location: Cincinnati, OH
- Epiduo Pediatric Acne Study - NCT01138735-48084
Conditions: Acne Location: Troy, MI
- Epiduo Pediatric Acne Study - NCT01138735-48202
Conditions: Acne Location: Detroit, MI
- Epiduo Pediatric Acne Study - NCT01138735-55432
Conditions: Acne Location: Fridley, MN
- Epiduo Pediatric Acne Study - NCT01138735-63117
Conditions: Acne Location: St. Louis, MO
- Epiduo Pediatric Acne Study - NCT01138735-66211
Conditions: Acne Location: Overland Park, KS
- Epiduo Pediatric Acne Study - NCT01138735-68144
Conditions: Acne Location: Omaha, NE
- Epiduo Pediatric Acne Study - NCT01138735-77030
Conditions: Acne Location: Houston, TX
- Epiduo Pediatric Acne Study - NCT01138735-92123
Conditions: Acne Location: San Diego, CA
- Epiduo Pediatric Acne Study - NCT01138735-95403
Conditions: Acne Location: Santa Rosa, CA
- Epiduo Pediatric Acne Study - NCT01138735-99204
Conditions: Acne Location: Spokane, WA
- Exploratory Study to Evaluate the Efficacy and Safety of CD07223 Gel in Subjects With Acne - NCT01106807-
Conditions: Acne Location: Hot Springs, AR
- Exploratory Study to Evaluate the Efficacy and Safety of CD07223 Gel in Subjects With Acne - NCT01106807-07662
Conditions: Acne Location: Rochelle Park, NJ
- Exploratory Study to Evaluate the Efficacy and Safety of CD07223 Gel in Subjects With Acne - NCT01106807-24501
Conditions: Acne Location: Lynchburg, VA
- Exploratory Study to Evaluate the Efficacy and Safety of CD07223 Gel in Subjects With Acne - NCT01106807-27103
Conditions: Acne Location: Winston-Salem, NC
- Exploratory Study to Evaluate the Efficacy and Safety of CD07223 Gel in Subjects With Acne - NCT01106807-40202
Conditions: Acne Location: Louisville, KY
- Exploratory Study to Evaluate the Efficacy and Safety of CD07223 Gel in Subjects With Acne - NCT01106807-48088
Conditions: Acne Location: Warren, MI
- Exploratory Study to Evaluate the Efficacy and Safety of CD07223 Gel in Subjects With Acne - NCT01106807-58104
Conditions: Acne Location: Fargo, ND
- Exploratory Study to Evaluate the Efficacy and Safety of CD07223 Gel in Subjects With Acne - NCT01106807-77845
Conditions: Acne Location: Bryan, TX
- Exploratory Study to Evaluate the Efficacy and Safety of CD07223 Gel in Subjects With Acne - NCT01106807-78759
Conditions: Acne Location: Austin, TX
- Musculoskeletal Effects of Isotretinoin During Acne Treatment in Pediatric Population - NCT00964119-53715
Conditions: Acne Location: Madison, WI
- Photoactive Porphyrins (PAP) Levels After Topical Visonac Application in Acne Patients - NCT01160848-78759
Conditions: Acne Vulgaris Location: Austin, TX
- Potential Research Study Participant Registry - NCT00710489-95816
Conditions: Acne - Actinic Keratosis - Dysplastic Nevi - Eczema - Psoriasis - Skin Cancer - Rosacea - Leg Ulcers - Foot Ulcers - Atopic Dermatitis Location: Sacramento, CA
- Safety and Efficacy of the Use of Botox on Acne - NCT00765375-60611
Conditions: Acne Vulgaris Location: Chicago, IL
- The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage - NCT00991198-27262
Conditions: Rosacea - Acne Vulgaris - Atopic Dermatitis - Seborrheic Dermatitis Location: High Point, NC
|
|
|
|
|
Didn't find what you were looking for? Try these alternatives:
Become A Member: To be notified of upcoming clinical trials in your
area please create a free member account.
Browse Studies: If you would like to browse all featured clinical trials
please Browse Studies.
Message Board: Join the discussion in our Health
and Clinical Trials Message Board.
|
|
|